Tom Morris

622 total citations
11 papers, 466 citations indexed

About

Tom Morris is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Tom Morris has authored 11 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Tom Morris's work include Prostate Cancer Treatment and Research (5 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and Statistical Methods in Clinical Trials (2 papers). Tom Morris is often cited by papers focused on Prostate Cancer Treatment and Research (5 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and Statistical Methods in Clinical Trials (2 papers). Tom Morris collaborates with scholars based in United Kingdom, Sweden and Belgium. Tom Morris's co-authors include Kevin Carroll, Peter Iversen, William A. See, David G. McLeod, Manfred P. Wirth, Laurence Collette, Kevin J. Carroll, Fritz H. Schröder, Tomasz Burzykowski and Don Newling and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and The Journal of Urology.

In The Last Decade

Tom Morris

11 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom Morris United Kingdom 7 311 97 67 64 63 11 466
Giancarlo Comeri Italy 10 371 1.2× 159 1.6× 65 1.0× 67 1.0× 35 0.6× 17 502
CJ Tyrrell United Kingdom 12 478 1.5× 254 2.6× 91 1.4× 39 0.6× 23 0.4× 17 682
Peggy S. Esper United States 11 319 1.0× 34 0.4× 99 1.5× 15 0.2× 22 0.3× 16 521
Gordon Wright Australia 4 197 0.6× 12 0.1× 55 0.8× 13 0.2× 22 0.3× 4 328
Luca Giuseppe Sgrò Italy 11 77 0.2× 90 0.9× 152 2.3× 22 0.3× 131 2.1× 31 447
Joachim Müller Switzerland 12 187 0.6× 37 0.4× 42 0.6× 10 0.2× 28 0.4× 23 393
Chia Kee‐Seng Denmark 5 51 0.2× 121 1.2× 89 1.3× 14 0.2× 61 1.0× 5 405
M Izuo Japan 12 55 0.2× 66 0.7× 103 1.5× 11 0.2× 95 1.5× 82 425
Denise M. Tenney United States 12 269 0.9× 24 0.2× 25 0.4× 8 0.1× 7 0.1× 14 449
Jean François Berdah France 9 154 0.5× 27 0.3× 74 1.1× 14 0.2× 15 0.2× 25 246

Countries citing papers authored by Tom Morris

Since Specialization
Citations

This map shows the geographic impact of Tom Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Morris more than expected).

Fields of papers citing papers by Tom Morris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Morris. The network helps show where Tom Morris may publish in the future.

Co-authorship network of co-authors of Tom Morris

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Morris. A scholar is included among the top collaborators of Tom Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Morris. Tom Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Plummer, Ruth, Alastair Greystoke, Debashis Sarker, et al.. (2024). A Phase 1a/1b Study of Fostroxacitabine Bralpamide (Fostrox) Monotherapy in Hepatocellular Carcinoma and Solid Tumor Liver Metastases. Journal of Hepatocellular Carcinoma. Volume 11. 2033–2047. 2 indexed citations
2.
Evans, T.R. Jeffry, Eric Van Cutsem, Hans Prenen, et al.. (2021). Phase I study of the novel pro-drug MIV-818 in patients with hepatocellular carcinoma, intra-hepatic cholangiocarcinoma or liver metastases.. Journal of Clinical Oncology. 39(3_suppl). 309–309. 2 indexed citations
3.
Morris, Tom & Stephen Santoreneos. (2012). Colloid cyst of velum interpositum: a rare finding. Journal of Neurosurgery Pediatrics. 9(2). 206–208. 10 indexed citations
4.
McLeod, David G., William A. See, Ira Klimberg, et al.. (2005). 674: The Bicalutamide Early Prostate Cancer Program: Findings of the North American Trial at Median 5.7 Years' Follow-Up. The Journal of Urology. 173(4S). 184–184. 1 indexed citations
6.
Iversen, Peter, Manfred P. Wirth, William A. See, et al.. (2004). Is the efficacy of hormonal therapy affected by lymph node status? data from the bicalutamide (Casodex) Early Prostate Cancer program. Urology. 63(5). 928–933. 12 indexed citations
8.
Tammela, Teuvo L.J., August Bakke, Pär Lodding, et al.. (2004). Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 Gy) significantly reduces the incidence of bicalutamide-induced gynecomastia. International Journal of Radiation Oncology*Biology*Physics. 60(2). 476–483. 67 indexed citations
10.
Kettle, Paul, et al.. (1991). Pseudothrombocytopenia--a cautionary tale.. PubMed. 60(2). 254–6. 1 indexed citations
11.
Alter, Milton, et al.. (1971). Multiple sclerosis among Orientals and Caucasians in Hawaii. Neurology. 21(2). 122–122. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026